Quebec drug maker recalls pain medicine amid potentially fatal health risks

JAMP Pharma Corp., a Quebec pharmaceutical maker, is recalling one lot of JAMP-Pregabalin pain medicine because bottles labelled to contain 50-milligram capsules may contain 150-milligram capsules instead. Health Canada announced the recall in an unusual Saturday evening statement. The announcement said the company’s mix-up could lead to patients taking a much larger dose of the…

Read More

He let snakes bite him hundreds of times. Now his blood might save lives – National

Tim Friede has been bitten by snakes hundreds of times — often on purpose. Now scientists are studying his blood in hopes of creating a better treatment for snake bites. Friede has long had a fascination with reptiles and other venomous creatures. He used to milk scorpions’ and spiders’ venom as a hobby and kept dozens of snakes at his Wisconsin home. Hoping to protect himself…

Read More

Wife of Quebec man who chose assisted death describes ER stay as coroner’s inquest opens

Warning: This story contains sensitive subject matter. Discretion is advised. The wife of a man who sought assisted death following a disastrous emergency room stay in Quebec is accusing the healthcare system of negligence. On Monday, Sylvie Brosseau spoke publicly as a coroner’s inquiry began into the death of her longtime partner, Normand Meunier, who…

Read More

Ozempic microdosing: Weight-loss hack or just a placebo? – National

As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing. Instead of following the standard dosing guidelines, some people are experimenting with smaller amounts of GLP-1 medications like Ozempic, Wegovy and Mounjaro. The reasons vary — from trying to stretch out expensive prescriptions to avoiding the side…

Read More

Study finds no evidence to support New Brunswick’s ‘mystery brain disease’

There is no evidence to support claims of a mystery brain disease in New Brunswick, says a new study that suggests the media may have played a role in feeding patients’ fears. Published Wednesday in the journal JAMA Neurology, the study reviewed the cases of 25 patients evaluated at two hospitals in New Brunswick and Ontario and found their symptoms could be traced back to several known neurodegenerative and non-neurodegenerative conditions. “Unfounded concerns that a…

Read More